Stylianos Bournazos

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 7

Top Topics

Roux En Y Gastric Bypass

Immune Response

Top Venues

Research square

Science (New York, N.Y.)

Nature microbiology

This page only lists publications with an associated author ORCID identifier.

Publications

Julia E Edgar, Stylianos Bournazos
Fc-FcγR interactions during infections: From neutralizing antibodies to antibody-dependent enhancement. Immunological reviews (2024)
Rachel Yamin, Kevin S Kao, Margaret R MacDonald, Tineke Cantaert, Charles M Rice, Jeffrey V Ravetch, Stylianos Bournazos
Human FcγRIIIa activation on splenic macrophages drives dengue pathogenesis in mice. Nature microbiology (2023)
Ramin Sedaghat Herati, David A Knorr, Laura A Vella, Luisa Victoria Silva, Lakshmi Chilukuri, Sokratis A Apostolidis, Alexander C Huang, Alexander Muselman, Sasikanth Manne, Oliva Kuthuru, Ryan P Staupe, Sharon A Adamski, Senthil Kannan, Raj K Kurupati, Hildegund C J Ertl, Jeffrey L Wong, Stylianos Bournazos, Suzanne McGettigan, Lynn M Schuchter, Ritesh R Kotecha, Samuel A Funt, Martin H Voss, Robert J Motzer, Chung-Han Lee, Dean F Bajorin, Tara C Mitchell, Jeffrey V Ravetch, E John Wherry
PD-1 directed immunotherapy alters Tfh and humoral immune responses to seasonal influenza vaccine. Nature immunology 23 (8) (2022)
Stylianos Bournazos, Hoa Thi My Vo, Veasna Duong, Heidi Auerswald, Sowath Ly, Anavaj Sakuntabhai, Philippe Dussart, Tineke Cantaert, Jeffrey V Ravetch
Antibody fucosylation predicts disease severity in secondary dengue infection. Science (New York, N.Y.) 372 (6546) (2021)
Jeffrey V Ravetch, Rachel Yamin, Andrew Jones, Hans-Heinrich Hoffmann, Kevin Kao, Rebecca Francis, Timothy P Sheahan, Ralph S Baric, Charles M Rice, Stylianos Bournazos
Fc-engineered antibody therapeutics with improved efficacy against COVID-19. Research square (2021)
Rachel Yamin, Andrew T Jones, Hans-Heinrich Hoffmann, Alexandra Schäfer, Kevin S Kao, Rebecca L Francis, Timothy P Sheahan, Ralph S Baric, Charles M Rice, Jeffrey V Ravetch, Stylianos Bournazos
Fc-engineered antibody therapeutics with improved anti-SARS-CoV-2 efficacy. Nature 599 (7885) (2021)
Stylianos Bournazos, Davide Corti, Herbert W Virgin, Jeffrey V Ravetch
Fc-optimized antibodies elicit CD8 immunity to viral respiratory infection. Nature 588 (7838) (2020)